lovastatin ratiopharm 40 mg
ratiopharm gmbh - lovastatin - tablett - 40 mg
metoclopramide orifarm 10 mg
orifarm generics a/s - metoklopramidhydrokloridmonohydrat - tablett - 10 mg
moxonidin actavis 0.2 mg
actavis group ptc ehf (1) - moksonidin - tablett, filmdrasjert - 0.2 mg
moxonidin actavis 0.4 mg
actavis group ptc ehf (1) - moksonidin - tablett, filmdrasjert - 0.4 mg
metoclopramide accord 10 mg
accord healthcare b.v. - metoklopramidhydrokloridmonohydrat - tablett - 10 mg
ranitidin ratiopharm 75 mg
ratiopharm gmbh - ranitidinhydroklorid - tablett, filmdrasjert - 75 mg
truxal 15 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 15 mg
truxal 25 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 25 mg
truxal 50 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 50 mg
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastiske midler - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).